CLASS II Drug recall · Reported 1 Jun 2022 · FDA Enforcement Report

Losartan Potassium & HCTZ Tablets 50mg/12.5 mg recalled

Preferred Pharmaceuticals is recalling Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, distributed in California, Florida. The recall was initiated on 3 May 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: K1721D, EXP: 4/30/2023, NDC: 68788-7758-09; Lot: K1021E, EXP: 7/31/2023, NDC: 68788-7758-09.
Quantity recalled31 bottles of 90 tables (Lot: K1721D); 5 bottles of 90 tablets (K1021E).

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0891-2022
FDA event ID
90148
Recalling firm
Preferred Pharmaceuticals, Anaheim, CA
Classification
Class II
Status
Terminated
Recall initiated
3 May 2022
FDA classified
24 May 2022
Reported
1 Jun 2022
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Potency & Assay

Timeline

3 May 2022Recall initiated by company
24 May 2022Classified by FDA+21 days
1 Jun 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09.

Where it was distributed

Within the U.S in FL and CA.

CaliforniaFlorida

Questions about this recall

Why was it recalled?

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Which lots are affected?

Lot: K1721D, EXP: 4/30/2023, NDC: 68788-7758-09; Lot: K1021E, EXP: 7/31/2023, NDC: 68788-7758-09.

Where was it sold?

Within the U.S in FL and CA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 90148

More recalls from Preferred Pharmaceuticals

All 55

Other Losartan & Hctz recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IILosartan Potassium & HCTZ Tablets 50mg/12.5 mg recalledPreferred PharmaceuticalsPotency & AssayCA, FL